ARTICLE | Company News
Management tracks: Settleman to lead Pfizer cancer R&D; plus Roivant, LabCorp and more
June 5, 2019 11:58 PM UTC
Pfizer Inc. (NYSE:PFE) hired Jeff Settleman as SVP and group head of oncology R&D, effective July 1. He was head of oncology research at Calico Life Sciences LLC (South San Francisco, Calif.) and prior to that, led discovery oncology at Genentech Inc. He succeeds Robert Abraham, who will retire at year end.
The autoimmune-focused Immunovant subsidiary of Roivant Sciences GmbH (Basel, Switzerland) hired Pete Salzmann as CEO. Salzmann was global clinical development leader for Olumiant baricitinib at Eli Lilly and Co. (NYSE:LLY). ...